Synapse - Karen L Siedlecki

Karen L Siedlecki

Research Focus

Former Employee. Medicine; Research Stdy Asst II

Recent additions – View all

Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
Journal Article

Morris, M. J.; Cordon-Cardo, C.; Kelly, W. K.; Slovin, S. F.; Siedlecki, K.; Regan, K. P.; DiPaola, R. S.; Rafi, M.; Rosen, N.; Scher, H. I.
Applied Immunohistochemistry & Molecular Morphology (2005)

Fulltext@MSK | Save
Fluorodeoxyglucose positron emission tomography as an outcome measure for castrate metastatic prostate cancer treated with antimicrotubule chemotherapy
Journal Article

Morris, M. J.; Akhurst, T.; Larson, S. M.; Ditullio, M.; Chu, E.; Siedlecki, K.; Verbel, D.; Heller, G.; Kelly, W. K.; Slovin, S.; more...
Clinical Cancer Research (2005)

Fulltext@MSK | Save
Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer
Journal Article

Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; Siedlecki, K.; Swanson, P.; Rafi, M.; more...
Clinical Cancer Research (2002)

Fulltext@MSK | Save

Co-authors at MSK

4

Morris
4

Scher
3

Kelly
3

Slovin
2

Akhurst
2

Cordon-...
2

Larson
2

Rosen
2

Schwartz
2

Verbel
1

Chu
1

Ditullio
1

Drobnjak
1

Heller
1

Macapinlac
1

Nunez
1

Osman
1

Regan
1

Swanson
1

Terry
1

Tong

Types of Work

Publications

Clinical Cancer Research (2)
Applied Immunohistochemistry & Molecular Morphology (1)
Urology (1)